V940, now called intismeran autogene, is an investigational personalised neoantigen therapy being studied with pembrolizumab for high-risk melanoma; it is not a general preventive cancer vaccine.
The short answer
The Phase 3 study compares V940 plus pembrolizumab with placebo plus pembrolizumab after melanoma surgery. The ClinicalTrials.gov record lists the study as active, not recruiting, with no posted results.
Why “personalised” matters
The therapy is designed from features of an individual patient’s tumour to target selected neoantigens. That is different from a routine vaccine manufactured identically for millions of healthy people. Creating a personalised treatment also raises practical questions about testing, manufacturing and timing.
What the trial measures
The primary outcome is recurrence-free survival. Secondary outcomes include distant-metastasis-free survival and overall survival. A Phase 3 trial is intended to test benefit and safety in a larger population, but its existence does not guarantee approval or a positive result.
What is not confirmed
There is no basis to say that V940 cures all cancers, replaces surgery or is ready for routine public access. Viral posts may combine early findings, other tumour types and future timelines. Patients should not change treatment based on a headline.
How to follow reliable updates
Use the ClinicalTrials.gov record, peer-reviewed publications, regulators and the sponsors’ dated announcements. Check whether an update reports interim data, final results, a regulatory submission or an approval; those terms are not interchangeable.
Practical checklist
- Identify the exact trial number
- Check recruitment and results status
- Separate melanoma from other cancers
- Do not treat an investigational product as approved
- Discuss treatment questions with an oncology team
What to verify before you act
This article is educational and is not medical advice. Anyone with melanoma or another cancer should discuss evidence and trial eligibility with qualified clinicians.
Frequently asked questions
Why is this topic trending now?
Search interest has risen, but a search trend alone does not prove that a viral claim is accurate. This guide separates confirmed information from assumptions.
What is the best first step?
Start with the official source linked below, check its update time and confirm that the information applies to your location and circumstances.
Official sources
Information checked on August 20, 2026. Rules and live situations can change, so verify the official source before acting.
Related : science and technology explainers
How to use this guide efficiently
For Moderna cancer vaccine, define the exact question first: are you checking a live outage, a date, eligibility, a safety action or an unconfirmed report? Open the primary source in a separate tab and compare its location, publication time and scope with your circumstances. This prevents a technically accurate but outdated answer from driving the wrong decision. If sources conflict, give more weight to the competent authority and the most recent dated update. A lack of official confirmation should be described as uncertainty, not turned into a definite denial or confirmation.
A three-stage action plan
Now: take only the urgent, reversible steps described above. Next: save relevant lot numbers, receipts, screenshots, correspondence or reference numbers. Later: recheck the official page when the situation is likely to change. For an immediate health threat, fraud, physical danger or legal deadline, an online guide cannot replace emergency services or a suitably qualified professional. The purpose of “Moderna cancer vaccine: What the V940 trial actually studies” is to help readers ask better questions and avoid acting on a viral headline alone.
Warning signs that require another check
Be cautious when a message demands immediate payment, asks for a password or verification code, guarantees an outcome, or provides no date and no primary source. Check names, model numbers, units, time zones and geography. Save the official URL rather than relying on a screenshot because live pages can carry corrections, expanded recall ranges, changed schedules or updated instructions.
Keeping the information useful
Share the conclusion together with its source and check time. Do not crop away qualifications or eligibility limits. If you return later, repeat the core check instead of assuming the situation stayed unchanged. This small discipline makes practical search content safer and more useful.